Innovotech Inc. IOT

TSX-V | Biotech | Biotechnology and antimicrobial research

General analysis — not personal advice.

Signal
SELL
Sentiment
3/10
Risk
8/10

A sharp revenue drop, ongoing losses, and weak price action increase downside risk and the likelihood of needing capital before a stable recovery is visible.

This picture changes. Follow Innovotech Inc. free — email when the signal or risk changes + a Sunday weekly brief.

Follow Innovotech Inc. free

Email when the signal or risk changes · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Latest news check: 17 Jun 2026
Exchange
TSX-V
Type
Biotech
Sector
Biotechnology and antimicrobial research

Price & valuation

Last close
CAD 0.09
2026-08-11
1 week
+12.5 %

Market sentiment

Sentiment has deteriorated following a weak Q1 print and a clear share-price decline; the development support is positive but does not offset near-term revenue and profitability pressure.

Why SELL?

A sharp revenue drop, ongoing losses, and weak price action increase downside risk and the likelihood of needing capital before a stable recovery is visible. The antimicrobial-services support is a potential catalyst, but it is early and without clear near-term revenue impact.
  • Reduce/trim exposure and wait for signs of recovery in the key customer project/order flow or a clearer funding plan; keep only a small watch position if high risk is tolerated.
We're already tracking Innovotech Inc. — here are the latest events we've registered

Recent News

  • Since 2026-06-07: On 2026-06-16 Innovotech announced a CFO transition with Bernard Grobbelaar stepping down and Craig Kalvin appointed effective immediately. The company also reported its AGM results the same day, with all resolutions approved including director re-elections, appointment of D&H Group LLP as auditors, and continuation of the Omnibus Security Based Compensation Plan; Arden Tse was appointed Vice Chair. No new financial reports, financings, or M&A have been announced.

Catalysts

Support for antimicrobial testing services and product enhancements

Dilution Risk

Assessment: High

What Firelda Watch includes for Innovotech Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — AI roundup of the week's news
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Innovotech Inc. will be delivered in the same format.

Own Innovotech Inc.? Create a free account and follow up to 3 companies — change history, weekly brief, and email when the picture changes. Upgrade to Watch for more slots and same-day alerts.

Follow 3 companies free

Email when the signal or risk changes · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Innovotech Inc. IOT
Innovotech Inc. — this picture changes. Follow free
Follow Innovotech Inc. free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.